Evidence map›Paper›PMID 21653834›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague.

Jr-Shiuan Lin, Frank M Szaba, Lawrence W Kummer, Brett A Chromy, Stephen T Smiley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Biomolecules · 2020
    Review
  10. Review
  11. Article
  12. Infection and immunity · 2019
    Article
  13. Review
  14. CCR2Infection and immunity · 2018
    Article
  15. Article
  16. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2016
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jr-Shiuan LinTrudeau Institute, Saranac Lake, NY 12983, USA.
Frank M Szaba
Lawrence W Kummer
Brett A Chromy
Stephen T Smiley
Trudeau Institute · USLawrence Livermore National Laboratory · US

Funding

Cell-mediated protection against pneumonic plagueR01AI061577 · NIAID · TRUDEAU INSTITUTE, INC. · PI LIN, JR-SHIUAN · 2004 to 2013
$3.8M
Roles for coagulation in immunityR01AI071295 · NIAID · TRUDEAU INSTITUTE, INC. · PI SMILEY, STEPHEN T · 2008 to 2011
$1.8M
NIAID NIH HHS R01 AI061577NIAID NIH HHS R01-AI061577NIAID NIH HHS R01 AI071295NIAID NIH HHS R01-AI071295
6 · The paper itself

Abstract

Septic bacterial pneumonias are a major cause of death worldwide. Several of the highest priority bioterror concerns, including anthrax, tularemia, and plague, are caused by bacteria that acutely infect the lung. Bacterial resistance to multiple antibiotics is increasingly common. Although vaccines may be our best defense against antibiotic-resistant bacteria, there has been little progress in the development of safe and effective vaccines for pulmonary bacterial pathogens. The Gram-negative bacterium Yersinia pestis causes pneumonic plague, an acutely lethal septic pneumonia. Historic pandemics of plague caused millions of deaths, and the plague bacilli's potential for weaponization sustains an ongoing quest for effective countermeasures. Subunit vaccines have failed, to date, to fully protect nonhuman primates. In mice, they induce the production of Abs that act in concert with type 1 cytokines to deliver high-level protection; however, the Y. pestis Ags recognized by cytokine-producing T cells have yet to be defined. In this study, we report that Y. pestis YopE is a dominant Ag recognized by CD8 T cells in C57BL/6 mice. After vaccinating with live attenuated Y. pestis and challenging intranasally with virulent plague, nearly 20% of pulmonary CD8 T cells recognize this single, highly conserved Ag. Moreover, immunizing mice with a single peptide, YopE(69-77), suffices to confer significant protection from lethal pulmonary challenge. These findings suggest YopE could be a valuable addition to subunit plague vaccines and provide a new animal model in which sensitive, pathogen-specific assays can be used to study CD8 T cell-mediated defense against acutely lethal bacterial infections of the lung.

Indexed as

Acute DiseaseAnimalsCD8-Positive T-LymphocytesCells, CulturedClone CellsDisease Models, AnimalEpitopes, T-LymphocyteImmunodominant EpitopesMiceMice, Inbred C57BLMice, KnockoutPlaguePneumonia, BacterialSurvival AnalysisVaccines, AttenuatedVaccines, SubunitEpitopes, T-LymphocyteImmunodominant EpitopesVaccines, AttenuatedVaccines, Subunit

Identifiers

PMID21653834
PMCPMC3131430
OpenAlexW2107321843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.